Population pharmacokinetic analysis of sifalimumab from a clinical phase IIb trial in systemic lupus erythematosus patients
about
Population pharmacokinetic analysis of sifalimumab from a clinical phase IIb trial in systemic lupus erythematosus patients
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Population pharmacokinetic ana ...... c lupus erythematosus patients
@ast
Population pharmacokinetic ana ...... c lupus erythematosus patients
@en
type
label
Population pharmacokinetic ana ...... c lupus erythematosus patients
@ast
Population pharmacokinetic ana ...... c lupus erythematosus patients
@en
prefLabel
Population pharmacokinetic ana ...... c lupus erythematosus patients
@ast
Population pharmacokinetic ana ...... c lupus erythematosus patients
@en
P2093
P2860
P356
P1476
Population pharmacokinetic ana ...... c lupus erythematosus patients
@en
P2093
Gabriel J Robbie
Warren Greth
Xiang-Qing Yu
P2860
P304
P356
10.1111/BCP.12864
P407
P577
2015-12-13T00:00:00Z